Initial fitness recovery of HIV-1 is associated with quasispecies heterogeneity and can occur without modifications in the consensus sequence

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Bordería, Antonio V ^a   Lorenzo Redondo, Ramon ^a   Pernas, Maria ^a   Casado, Concepción ^a   Alvaro, Tamara ^a   Domingo, Esteban ^b,c   Lopez Galindez, Cecilio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CSIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CELL CULTURE; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIAL ACTIVITY; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; VIRAL GENETICS; VIRUS GENOME; GENETIC SELECTION; GENETICS; METHODOLOGY; MUTATION; REPRODUCTIVE FITNESS; VIROLOGY; VIRUS CULTURE;

CONSENSUS SEQUENCE; GENETIC FITNESS; GENETIC HETEROGENEITY; GENOME, VIRAL; HIV-1; MUTATION; SELECTION, GENETIC; SERIAL PASSAGE; VIROLOGY;

EID: 77956411264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010319     Document Type: Article

References (46)

1. Domingo E, Parrish CR, Holland JJ, eds. Origin and Evolution of Viruses (second Edition): Elservier.
2. Sanchez-Palomino S, Rojas JM, Martinez MA, Fenyö EM, Najera R, et al. (1993) Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture. J Virol 67(5): 2938-2943.
3. Yuste E, Sanchez-Palomino S, Casado C, Domingo E, Lopez-Galindez C (1999) Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events. J Virol 73(4): 2745-2751.
4. Yuste E, Borderia AV, Domingo E, Lopez-Galindez C (2005) Few Mutations in the 59 Leader Region Mediate Fitness Recovery of Debilitated Human Immunodeficiency Type 1 Viruses. J Virol 79: 5421-5427.
5. Eigen M (1971) Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften 58: 465-523.
6. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, et al. (1985) The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance-a review. Gene 40: 1-8.
7. Eigen MaBC (1988) Sequence space and quasispecies distribution. In: Domingo E, Holland JJ, Ahlquist P, eds. RNA genetics. Boca Raton: CRC Press. pp 211-245.
8. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439: 344-348.
9. Pfeiffer JK, Kirkegaard K (2005) Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1: e11.
10. Jerzak GV, Bernard K, Kramer LD, Shi PY, Ebel GD (2007) The West Nile virus mutant spectrum is host-dependant and a determinant of mortality in mice. Virology 360: 469-476.
11. Sauder CJ, Vandenburgh KM, Iskow RC, Malik T, Carbone KM, et al. (2006) Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350: 48-57.
12. Vignuzzi M, Wendt E, Andino R (2008) Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med 14: 154-161.
13. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, et al. (2008) Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing. J Virol. pp 3952-3970.
14. Escarmis C, Davila M, Domingo E (1999) Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J Mol Biol 285: 495-505.
15. Novella IS, Duarte EA, Elena SF, Moya A, Domingo E, et al. (1995) Exponential increases of RNA virus fitness during large population transmissions. Proceedings of the National Academy of Sciences of the United States of America 92: 5841-5844.
16. Yuste E, Lopez-Galindez C, Domingo E (2000) Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1. J Virol 74: 9546-9552.
17. Lopez-Galindez C, Lopez JA, Melero JA, de la Fuente L, Martinez C, et al. (1988) Analysis of genetic variability and mapping of point mutations in influenza virus by the RNase A mismatch cleavage method. Proc Natl Acad Sci USA 85: 3522-3526.
18. Thome KC, Radfar A, Rosenberg N (1997) Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells. J Virol. pp 8149-8156.
19. Larder B, Kemp S (1989) Multiple mutations in HIV-1 reverse trans-criptase confer high level resistance to zidovudine (AZT). Science 246: 1155-1158.
20. Diez J, Davila M, Escarmis C, Mateu MG, Dominguez J, et al. (1990) Unique amino acid subtitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cellculture. Proc Natl Acad Sci USA 64: 5519-5528.
21. Lopez-Galindez C, Rojas JM, Najera R, Richman DD, Perucho M (1991) Characterization of genetic variation and 39-azido-39-deoxythymidine- resistance mutations of human immunodeficiency virus by the RNase A mismatch cleavage method. Proc Natl Acad Sci USA 88: 4280-4284.
22. Olivares I, Shaw G, Lopez-Galindez C (1997) Phenotypic switch in a spanish HIV Type 1 isolate on serial passage on MT-4 cells. AIDS Res Hum Retroviruses 13(11): 979-984.
23. Baranowski E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E, et al. (1998) Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol 72: 6362-6372.
24. Sanz-Ramos M, Diaz-San Segundo F, Escarmis C, Domingo E, Sevilla N (2008) Hidden Virulence Determinants in a Viral Quasispecies In Vivo. J Virol. pp 10465-10476.
25. Novella IS, Ebendick-Corpus BE (2004) Molecular basis of fitness loss and fitness recovery in vesicular stomatitis virus. J Mol Biol 342: 1423-1430.
26. Gonzalez-Lopez C, Gomez-Mariano G, Escarmis C, Domingo E (2005) Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe. Infect Genet Evol 5: 366-374.
27. Domingo E, Gonzalez-Lopez C, Pariente N, Airaksinen A, Escarmis C (2005) Population dynamics of RNA viruses: the essential contribution of mutant spectra. Arch Virol Suppl. pp 59-71.
28. Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, et al. (2007) HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. Aids 21: 215-223.
29. Brander C, Walker BD (1999) T lymphocyte responses in HIV-1 infection: implications for vaccine development. Curr Opin Immunol 11: 451-459.
30. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MBA (1994) Virus-specific CD8+cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. Journal of Virology 68: 6103-6110.
31. Kaslow RA, Carrington M, Apple R, Park L, Muoz A, et al. (1996) Influence of combinations of human major histocompatibility complex geners on the course of HIV-1 infection. Nature Medicine 2: 405-411.
32. Cao J, McNevin J, Holte S, Fink L, Corey L, et al. (2003) Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+T cells in primary HIV-1 infection. J Virol 77: 6867-6878.
33. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, et al. (2004) Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 199: 905-915.
34. Altfeld M, Addo MM, Shankarappa R, Lee PK, Allen TM, et al. (2003) Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 77: 7330-7340.
35. Goonetilleke N, Liu MKP, Salazar-Gonzalez JF, Ferrari G, Giorgi E, et al. (2009) The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. pp jem.20090365.
36. Richman DD, Wrin T, Little SJ, Petropoulos CJ (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci USA 100: 4144-4149.
37. Meyerhans A, Cheynier R, Albert J, Seth M, Kwok S, et al. (1989) Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58: 901-910.
38. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, et al. (2005) Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression. J Virol 79: 9006-9018.
39. Wolinsky SM, Korber BT, Neumann AU, Daniels M, Kunstman KJ, et al. (1996) Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272: 537-542.
40. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, et al. (1999) Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73: 10489-10502.
41. Biebricher CK, Eigen M (2006) What is a quasispecies? Curr Top Microbiol Immunol 299: 1-31.
42. Eigen M, Biebricher CK (1988) Sequence space and quasispecies distribution; Domingo E, Holland JJ, Ahlquist P, eds. Boca RatonFlorida: CRC Press. pp 211-245.
43. Harada S, Koyanagi Y, Yamamoto N (1985) Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
44. Holland JJ, de la Torre JC, Clarke DK, Duarte E (1991) Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J Virol 65(6): 2960-2967.
45. Kuiken C, Leitner T, Foley B, Hahn B, Marx P, et al. (2009) HIV Sequence Compendium 2009. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos New Mexixco LA-UR 09-03280.
46. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.